Feature Selection in Cancer Classification: Utilizing Explainable Artificial Intelligence to Uncover Influential Genes in Machine Learning Models
AI · 27.12.2024 · 6 (1) · 2
DOI: 10.3390/ai6010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift AI, online erschienen am 27.12.2024. Verfasst von Matheus Dalmolin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Abstract (Originalsprache)
This study investigates the use of machine learning (ML) models combined with explainable artificial intelligence (XAI) techniques to identify the most influential genes in the classification of five recurrent cancer types in women: breast cancer (BRCA), lung adenocarcinoma (LUAD), thyroid cancer (THCA), ovarian cancer (OV), and colon adenocarcinoma (COAD). Gene expression data from RNA-seq, extracted from The Cancer Genome Atlas (TCGA), were used to train ML models, including decision trees (DTs), random forest (RF), and XGBoost (XGB), which achieved accuracies of 98.69%, 99.82%, and 99.37%, respectively. However, the challenges in this analysis included the high dimensionality of the dataset and the lack of transparency in the ML models. To mitigate these challenges, the SHAP (Shapley Additive Explanations) method was applied to generate a list of features, aiming to understand which characteristics influenced the models’ decision-making processes and, consequently, the prediction results for the five tumor types. The SHAP analysis identified 119, 80, and 10 genes for the RF, XGB, and DT models, respectively, totaling 209 genes, resulting in 172 unique genes. The new list, representing 0.8% of the original input features, is coherent and fully explainable, increasing confidence in the applied models. Additionally, the results suggest that the SHAP method can be effectively used as a feature selector in gene expression data. This approach not only enhances model transparency but also maintains high classification performance, highlighting its potential in identifying biologically relevant features that may serve as biomarkers for cancer diagnostics and treatment planning.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Zitieren
APA
Dalmolin, M., Azevedo, K. S., Souza, L. C. D., Farias, C. B. D., Lichtenfels, M., & Fernandes, M. A. C. (2024). Feature Selection in Cancer Classification: Utilizing Explainable Artificial Intelligence to Uncover Influential Genes in Machine Learning Models. AI, 6(1), 2. https://doi.org/10.3390/ai6010002
Vancouver
Dalmolin M, Azevedo KS, Souza LCD, Farias CBD, Lichtenfels M, Fernandes MAC. Feature Selection in Cancer Classification: Utilizing Explainable Artificial Intelligence to Uncover Influential Genes in Machine Learning Models. AI. 2024;6(1):2. doi:10.3390/ai6010002
BibTeX
@article{Dalmolin2024,
author = {Dalmolin, Matheus and Azevedo, Karolayne S. and Souza, Luísa C. de and Farias, Caroline B. de and Lichtenfels, Martina and Fernandes, Marcelo A. C.},
title = {Feature Selection in Cancer Classification: Utilizing Explainable Artificial Intelligence to Uncover Influential Genes in Machine Learning Models},
journal = {AI},
year = {2024},
volume = {6},
number = {1},
pages = {2},
doi = {10.3390/ai6010002}
}
EUVIMED